PPF Biotech B.V. 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-05 4:21 pm Purchase |
2022-09-23 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 14,613,275 16.100% |
1,000 (+0.01%) |
Filing |
| 2021-06-23 4:00 pm Purchase |
2021-05-18 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 14,612,275 27.900% |
361,255 (+2.53%) |
Filing |
| 2020-08-13 4:09 pm Purchase |
2020-08-12 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 14,251,020 27.300% |
553,075 (+4.04%) |
Filing |
| 2020-08-03 4:12 pm Purchase |
2020-07-31 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 13,697,945 26.200% |
604,370 (+4.62%) |
Filing |
| 2020-07-20 4:10 pm Purchase |
2020-07-17 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 13,093,575 25.100% |
519,266 (+4.13%) |
Filing |
| 2020-07-06 4:15 pm Purchase |
2020-07-02 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 12,574,309 24.100% |
531,029 (+4.41%) |
Filing |
| 2020-06-15 4:52 pm Purchase |
2020-06-12 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 12,043,280 23.100% |
3,395,057 (+39.26%) |
Filing |